Ranking · Unmet Need
Research Gap Index
Burden percentile minus research-activity percentile (publications, last 5 years) within the same scope. Positive values flag cancers with high mortality burden but comparatively little literature. Caveat (Phase 1): literature counts are query-based per entity (query stored on each row); they are not aggregated over descendants.
Computedci-research-gap-v1unit: percentile pointshigher = worseAll metrics
| Rank | Δ | Cancer | Research Gap Index (percentile points) | Percentile | Confidence | Sources | Why #n? |
|---|---|---|---|---|---|---|---|
| 1 | = | Malignant Central Nervous System Neoplasm | +70 | 100 | Medium confidence | cdc-uscspubmedcdc-wonderseeriarc-globocan | inputs
ranking row 2606952 |
| 2 | = | Malignant Uterine Corpus Neoplasm | +43.3 | 96.7 | Medium confidence | cdc-uscspubmedcdc-wonderseeriarc-globocan | inputs
ranking row 2606953 |
| 3 | = | Malignant Kidney Neoplasm | +20 | 93.3 | Medium confidence | cdc-uscspubmedcdc-wonderseeriarc-globocan | inputs
ranking row 2606955 |
| 3 | ▲1 | Malignant Pancreatic Neoplasm | +20 | 93.3 | Medium confidence | cdc-uscspubmedcdc-wonderseeriarc-globocan | inputs
ranking row 2606954 |
| 5 | = | Malignant Colon Neoplasm | +16.7 | 86.7 | Medium confidence | cdc-uscspubmedcdc-wonderseeriarc-globocan | inputs
ranking row 2606956 |
| 6 | = | Malignant Liver Neoplasm | +16.6 | 83.3 | Medium confidence | cdc-uscspubmedcdc-wonderseeriarc-globocan | inputs
ranking row 2606957 |
| 7 | = | Malignant Esophageal Neoplasm | +13.4 | 80 | Medium confidence | cdc-uscspubmedcdc-wonderseeriarc-globocan | inputs
ranking row 2606958 |
| 7 | = | Non-Hodgkin Lymphoma | +13.4 | 80 | Medium confidence | cdc-uscspubmedcdc-wonderseeriarc-globocan | inputs
ranking row 2606959 |
| 9 | = | Malignant Salivary Gland Neoplasm | +10 | 73.3 | Medium confidence | cdc-uscspubmedcdc-wonderseeriarc-globocan | inputs
ranking row 2606960 |
| 10 | = | Malignant Vulvar Neoplasm | +6.6 | 70 | Medium confidence | cdc-uscspubmedcdc-wonderseeriarc-globocan | inputs
ranking row 2606961 |
| 11 | ▲1 | Malignant Laryngeal Neoplasm | +3.4 | 66.7 | Medium confidence | cdc-uscspubmedcdc-wonderseeriarc-globocan | inputs
ranking row 2606962 |
| 12 | ▲1 | Malignant Lung Neoplasm | +3.3 | 63.3 | Medium confidence | cdc-uscspubmedcdc-wonderseeriarc-globocan | inputs
ranking row 2606963 |
| 12 | ▼1 | Multiple Myeloma | +3.3 | 63.3 | Medium confidence | cdc-uscspubmedcdc-wonderseeriarc-globocan | inputs
ranking row 2606964 |
| 14 | = | Cutaneous Melanoma | 0 | 56.7 | Medium confidence | cdc-uscspubmedcdc-wonderseeriarc-globocan | inputs
ranking row 2606965 |
| 14 | ▲2 | Malignant Anal Neoplasm | 0 | 56.7 | Medium confidence | cdc-uscspubmedcdc-wonderseeriarc-globocan | inputs
ranking row 2606967 |
| 14 | ▲2 | Malignant Bladder Neoplasm | 0 | 56.7 | Medium confidence | cdc-uscspubmedcdc-wonderseeriarc-globocan | inputs
ranking row 2606966 |
| 14 | ▲7 | Malignant Rectal Neoplasm | 0 | 56.7 | Medium confidence | cdc-uscspubmedcdc-wonderseeriarc-globocan | inputs
ranking row 2606968 |
| 18 | ▼2 | Malignant Vaginal Neoplasm | -3.4 | 43.3 | Medium confidence | cdc-uscspubmedcdc-wonderseeriarc-globocan | inputs
ranking row 2606969 |
| 19 | ▲2 | Malignant Mesothelioma | -3.4 | 40 | Medium confidence | cdc-uscspubmedcdc-wonderseeriarc-globocan | inputs
ranking row 2606970 |
| 20 | ▲6 | Malignant Prostate Neoplasm | -6.6 | 36.7 | Medium confidence | cdc-uscspubmedcdc-wonderseeriarc-globocan | inputs
ranking row 2606971 |
| 21 | ▼1 | Malignant Hypopharyngeal Neoplasm | -6.6 | 33.3 | Medium confidence | cdc-uscspubmedcdc-wonderseeriarc-globocan | inputs
ranking row 2606972 |
| 22 | ▲3 | Malignant Nasopharyngeal Neoplasm | -6.7 | 30 | Medium confidence | cdc-uscspubmedcdc-wonderseeriarc-globocan | inputs
ranking row 2606973 |
| 23 | = | Leukemia | -6.7 | 26.7 | Medium confidence | cdc-uscspubmedcdc-wonderseeriarc-globocan | inputs
ranking row 2606974 |
| 23 | ▲3 | Malignant Breast Neoplasm | -6.7 | 26.7 | Medium confidence | cdc-uscspubmedcdc-wonderseeriarc-globocan | inputs
ranking row 2606975 |
| 25 | ▲5 | Malignant Ovarian Neoplasm | -20 | 20 | Medium confidence | cdc-uscspubmedcdc-wonderseeriarc-globocan | inputs
ranking row 2606976 |
| 25 | ▲5 | Malignant Testicular Neoplasm | -20 | 20 | Medium confidence | cdc-uscspubmedcdc-wonderseeriarc-globocan | inputs
ranking row 2606977 |
| 27 | ▲5 | Hodgkin Lymphoma | -23.3 | 13.3 | Medium confidence | cdc-uscspubmedcdc-wonderseeriarc-globocan | inputs
ranking row 2606978 |
| 27 | ▲5 | Malignant Penile Neoplasm | -23.3 | 13.3 | Medium confidence | cdc-uscspubmedcdc-wonderseeriarc-globocan | inputs
ranking row 2606979 |
| 29 | ▲6 | Malignant Thyroid Gland Neoplasm | -30 | 6.7 | Medium confidence | cdc-uscspubmedcdc-wonderseeriarc-globocan | inputs
ranking row 2606980 |
| 30 | ▲4 | Malignant Gastric Neoplasm | -40 | 3.3 | Medium confidence | cdc-uscspubmedcdc-wonderseeriarc-globocan | inputs
ranking row 2606981 |
| 31 | ▲5 | Malignant Cervical Neoplasm | -43.3 | 0 | Medium confidence | cdc-uscspubmedcdc-wonderseeriarc-globocan | inputs
ranking row 2606982 |
Data updated 16 hours agoSource updated unknown31 eligible entities · inputs hash 6479d73d7b11d2aef5f35013